Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

General linearized biexponential model for QSAR data showing bilinear-type distribution.

Peter Buchwald1

  • 1IVAX Research, Inc., 4400 Biscayne Blvd., Miami, Florida 33137, USA. Peter_Buchwald@ivax.com

Journal of Pharmaceutical Sciences
|October 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LDLR-OPN Interaction Drives COVID-19 Myocarditis Through Monocyte Recruitment.

JACC. Basic to translational science·2026
Same author

Cyclodextrin Complexes for Clinical Translatability: Applications for Cladribine and Retrometabolically Designed Estredox.

International journal of molecular sciences·2025
Same author

Assessing the rate dependence of the first phase of glucose-stimulated insulin secretion: dynamic perifusion studies with isolated human pancreatic islets.

American journal of physiology. Endocrinology and metabolism·2025
Same author

Drug-Integrating Amphiphilic Nano-Assemblies: 3. PEG-PPS/Palmitate Nanomicelles for Sustained and Localized Delivery of Dexamethasone in Cell and Tissue Transplantations.

Pharmaceutics·2025
Same author

Commentary: The flexibility of SABRE, a new quantitative receptor function model, in fitting challenging concentration-effect data.

Frontiers in pharmacology·2025
Same author

Assessing the Rate-Dependence of the First Phase of Glucose-Stimulated Insulin Secretion: Dynamic Perifusion Studies with Isolated Human Pancreatic Islets.

bioRxiv : the preprint server for biology·2025
Same journal

Green, renewable, or low-carbon? A framework for informed solvent selection in pharmaceutical sciences.

Journal of pharmaceutical sciences·2026
Same journal

Theranostic potential of ramucirumab functionalized magnetoliposomes for targeted delivery of sorafenib and MRI.

Journal of pharmaceutical sciences·2026
Same journal

Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

Journal of pharmaceutical sciences·2026
Same journal

Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

Journal of pharmaceutical sciences·2026
Same journal

A mathematical framework for predicting tablet weight variability from blend particle size distribution and tooling geometry.

Journal of pharmaceutical sciences·2026
Same journal

Recrystallization can stop nitrosamine formation in ranitidine hydrochloride.

Journal of pharmaceutical sciences·2026
See all related articles

A new linearized biexponential (LinBiExp) model effectively describes complex QSAR data, overcoming limitations of linear and parabolic approaches. This versatile model handles asymmetric data and extends linear models for broader applicability in drug discovery.

Area of Science:

  • Quantitative Structure-Activity Relationship (QSAR) studies
  • Computational Chemistry
  • Medicinal Chemistry

Background:

  • Quantitative Structure-Activity Relationship (QSAR) analyses are often limited by data exhibiting maxima or minima, which cannot be adequately described by simple linear functions.
  • Existing models like Hansch-type parabolic models struggle with asymmetrical data and do not naturally extend linear relationships.

Purpose of the Study:

  • To introduce a general linearized biexponential (LinBiExp) model capable of describing data with bilinear-type distributions.
  • To provide a more versatile and intuitive alternative to existing QSAR models for various physicochemical descriptors.

Main Methods:

  • Development of the LinBiExp model using a differential equation-based approach, starting from general assumptions about equilibrium and kinetic processes.

Related Experiment Videos

  • Application of the model to various descriptors, including lipophilicity (log P) and molecular volume.
  • Integration of the LinBiExp model within the framework of linear free energy relationship (LFER) approaches.

    • Main Results:

    • The LinBiExp model successfully describes data with bilinear-type distributions, accommodating both linear and non-linear relationships.
    • It offers a natural extension of linear models and effectively fits asymmetrical data, unlike traditional parabolic models.
    • The model demonstrates broad applicability across diverse fields, including toxicity, antimicrobial activity, anticholinergic activity, and receptor binding.

    Conclusions:

    • The linearized biexponential (LinBiExp) model provides a powerful and flexible tool for QSAR analyses, overcoming limitations of previous methods.
    • Its ability to model complex data distributions and its intuitive nature make it valuable for drug discovery and related fields.
    • LinBiExp represents a significant advancement in applying linear free energy relationships to diverse biological and chemical phenomena.